The approval and the concession of the Health Registration 201300 4713 dated February 25th 2013, in force until 2013, by the National Institute of Food and Drug Monitoring as a body of the Colombian Ministry of Health and Social Protection, in favor of the Absorb BVS® bioresorbable scaffold, under the name of bioresorbable medicated stent, has created high expectations regarding the introduction of these scaffolds in the therapeutic repertoire of the interventional cardiologist for treatment of selected patients with coronary disease. The security and efficiency that they have shown in comparison to the drug-eluting stents, with results of non-inferiority and offering various advantages, have been the reasons why they have been called the fourth revolution. This article reviews the existing scaffolds and their operating methods, as well as their advantages and limitations.